Background: Coronary heart disease (CHD), a complication of hypertension, is one of the most important and common causes of morbidity, hospitalisation, and mortality among hypertensive population. In recent decades, increased urbanisation and changes to lifestyle, diet and physical activity in developing countries have led to a major increase in the population incidence of chronic diseases including CHD. Poor medication adherence is one of the leading causes of failure to achieve hypertension control. The objective of this systematic review is to describe the prevalence of non-adherence to antihypertensive medications among hypertensive population in developing countries and identify factors associated with it. Methods: A literature search was conducted using the following scholarly electronic databases: Proquest, PubMed, JSTOR and Science Direct. The online search engine, Google Scholar was also used to search for and identify relevant papers. Peer-reviewed fulltext articles published in English on hypertensive adults in developing countries that measured adherence to antihypertensive medications and their associations with different factors were eligible for inclusion. The review followed the PRISMA reporting and analytical guidelines for systematic reviews. Results: In all, 42 studies conducted across 19 developing countries were selected for the review. The mean prevalence of medication non-adherence (MNA) among the select hypertensive population was 47.34%. Very few studies were conducted in community settings and except for one, no study examined gender differences in MNA factors. The analysis revealed a range of factors that can influence MNA including low household income and socioeconomic status; knowledge and beliefs of hypertension and its management; avoiding side effects of medications; cost of medication; use of herbal preparations; absence of symptoms; irregular follow-up; and dissatisfaction with the treatment and health services provided. There was a general lack of consideration of role of health system in health care delivery, self-efficacy, cultural barriers, per- There was also a lack of gender-specific research which is necessary at community settings given the social and economic vulnerabilities faced by women in developing countries that may affect adherence to antihypertensive medications. Conclusions: Future research in developing countries should consider individual risk perceptions, cultural barriers, gender and the role of local health system in health care delivery when assessing MNA among hypertensive population at community settings.
Methods
Literature search was conducted using the electronic databases: Proquest, PubMed, JSTOR and Science Direct for articles published during 2000-15. The online search engine, Google Scholar was also used to search for and identify likely papers. The search strategy included the following terms:
• adherence, non-adherence, compliance, persistence (related to medication adherence).
• hypertension, high blood pressure (Blood pressure ≥140/≥90 mm of Hg).
• belief, perception of hypertension and • developing countries (the World Bank classifies all low-and middle-income countries as developing countries-however, this term is not intended to imply that all economies in the group are experiencing similar development or that other economies have reached a preferred or final stage of development). 2) Identify factors related to medication adherence with the antihypertensive treatment.
3) Enrolled hypertensive adults (18 years and older).
4) Published in English as a peer-reviewed full-text article.
We excluded studies that measured adherence of other chronic diseases or were conducted in developed countries and published in a non-English language.
dies.To check the quality of quantitative studies the National Collaborating Centre for Methods and Tools' quality assessment tool for quantitative studies was used [22] . Qualitative studies were checked based on NICE guidelines [23] .
A standardised data extraction form was used to record the citation details, methodology and objectives, and main findings of each paper. The following information was extracted and tabulated by the first reviewer and verified by the second and third reviewers: author name, date of publication, the country in which research was conducted, sample size, sampling method, study design, sex (% female), the adherence measure used, key findings and any statistical information (odd ratios, 95% CI p-value, correlation coefficients). A summary of the studies reviewed was provided in Table 1 . A meta-analysis of the findings was not possible due to the heterogeneity in important aspects of methodology of the Nagarkar et al. [27] MMAS 8 India; N = 174
Bilal et al. [60] Questionnaire Pakistan; N = 113
Lalic et al. [28] MMAS 8 Serbia; N = 170
Sex
Khanam et al. [29] Questionnaire Bangladesh; N = 29,960
Praveen et al. [30] Questionnaire India; N = 804
Ismael et al. [31] Questionnaire Iraq; N = 200
Joho et al. [32] Questionnaire Tanzania; N = 135
Level of education
Bhandari et al. [33] MMAS 4 Nepal; N = 154
Boima et al. [26] MMAS 8 Ghana and Nigeria; N = 357
Household income and employment
Hussain et al. [34] Questionnaire Bangladesh; N = 120
Gelaw et al. [35] Questionnaire Ethiopia; N = 91
Bilal et al. [40] Questionnaire Pakistan; N = 113
Type of family Nagarkar et al. [27] MMAS 8 India; N = 174
Comorbidities
Hareri et al. [36] .
Questionnaire Ethiopia; N = 365
Ambaw et al. [37] MMAS 4 Ethiopia; N = 384
Al-Ramahi et al. [38] . MMAS 8 Palestine ; N = 450
Use of herbal preparation Boima et al. [26] .
MMAS 8 Ghana and Nigeria; N = 357
Saleem et al. [39] Qualitative Pakistan
Odusola et al. [40] Qualitative Nigeria Open Journal of Epidemiology selected studies including sampling procedure (random/purposive) population ages, study settings (hospital/clinic/community), study design (cross-sectional/ longitudinal/qualitative) and measurement procedure of medication adherence.
Descriptive analysis of studies examining similar variables and any association observed were considered to offer a simple indication of the level of evidence.
Summary ranges of quantitative proportions and measures relating to prevalence and factors associated with MNA were compiled and presented. The evidence from the studies was synthesised and presented in a narrative review. The review followed the PRISMA reporting guidelines [24] .
Result

Description of the Studies
The selected studies were conducted in developing countries in Asia ( Nigeria was mixed methods in type, comprising both quantitative and qualitative methods for data collection [25] . A summary of the characteristics and the aim of each study are shown in Table A1 .
The five qualitative studies were from India (1), Pakistan (1), Congo (1), Malaysia (1) and Nigeria (1) . Three studies used one-to-one qualitative interviews, one study used focus group discussion, and one used a combination of these methods. Further details of the study designs and results are presented in Table  A1 . In all of the studies, the study population included both males and females. Overall women comprised 55.98% of study participants.
Reported Adherence to Antihypertensive Treatment
To measure medication adherence, 21 (50%) of the quantitative studies used the Morisky Medication Adherence Scale'. Other scales used in the four different studies were: Medicines Team Questionnaire-Qualiaids (QAM-Q) (1); Beliefs about Medicine Questionnaire (BMQ) (1); Hill-Bone Adherence to Blood Pressure Therapy Scale (1); Drug Attitude Inventory (DAI-10) (1); One study used Medication Event Monitoring System (MEMS) and one used pill count to measure adherence. The remaining studies used questionnaires. Among them, eleven studies used structured questionnaires with established reliability and or validity, while eight studies (33%) did not cite information on their reliability or validity.
The rate of MNA among hypertensive population ranged from 23% -6.76% with the mean being 47.34%.
Factors Impacting on Adherence
The identified factors related to MNA in the reviewed studies could be catego-Open Journal of Epidemiology rised into seven domains: demographic; psychosocial; perceptions regarding hypertension and its severity; perceptions regarding antihypertensive treatment; perceived barriers to treatment adherence; treatment and disease related factors; and health care services.
Demographic Factors
Sixteen studies reported significant associations between demographic variables (such as age, sex, level of education, types of family, household income, employment, type of family, co-morbidities and use of herbal preparations)and MNA to hypertensive therapy ( Table 1 ).
The effect of age on medication adherence showed conflicting results. Younger age was found to be significantly associated with MNA to hypertensive medications in India (≤57 years) [OR (odd ratio) 3.348; 95% Confidence Interval (CI): 1.665 -6.732] [27] , Palestine (<45 years) (OR = 0.40; 95% CI: 0.157 -0.99) [38] and Pakistan (≤51 years) (OR = 1.0; 95% CI: 1.00 -1.04). The mean age of hypertensive patients who were not adherent to medications was 54.5 ± 13.2 years while those who were adherent had a mean age of 60.9 ± 12.1 years ( < 0.001) in Ghana and Nigeria [26] . On the other hand, a significantly lower level of adherence was identified in a study with elderly patients in Serbia. In this study patients less than 65 years were found to be more likely to adhere to their prescribed treatment, compared to older patients (AOR = 6.0; 95% CI: 2.76 -13.04) [28] .
Being female was independently and significantly associated with poor adherence in a study in India (AOR = 2.95; 95% CI: 1.39 -6.24) with hypertensive women 2.95 times more likely to be non-adherent to their medications than men [30] . A study in Iraq also revealed that female hypertensive patients (61.7%) were more non-adherent than male (30.3%) patients [31] . On the other hand, MNA was significantly associated with male gender in Pakistan ( = 0.008) [60] , Tanzania ( = 0.044), [32] and Bangladesh (AOR = 1.67; 95% CI: 1.42 -1.97) [29] . However, several studies [26] [33] [34] [41] [42] found no significant association between gender and MNA among hypertensive patients. Thus, the effect of gender on MNA showed conflicting results across countries.
Hypertensive patients in Nepal who were illiterate almost five times less likely to be adherent to medications than those who were literate (AOR = 5.34, 95% CI: 1.23 -23) [33] . Similarly, lower level of education was significantly associated with MNA among hypertensive patients in Bangladesh (OR = 6.34; 95% CI: 1.65 -24.41) [34] . On the other hand, formal education was associated with MNA ( = 0.001) in Ghana and Nigeria [26] . A study in India found that educational level was not a significant contributing factor to non-adherence [43] . From these results, it seems that educational level may not always be a good predictor of MNA.
Hypertensive patients with low monthly income (AOR = 11.60; 95% CI: 3.77 -35.65) in Bangladesh [34] and Ethiopia ( = 0.04) [35] were more non-adherent Open Journal of Epidemiology to their medications. In Pakistan, [44] the likelihood of MNA was also found to be higher among unemployed persons ( = 0.002) and people with low socioeconomic status ( = 0.046). Hypertensive patients who had private businesses were 72% less likely to adhere to medication compared to government employees (AOR = 0.28, 95% CI: 0.130 -0.606) in Ethiopia [45] . Hypertensive patients living in a nuclear family setup in India were more likely to have lower adherence to medication as compared to staying in the extended family (OR = 2.67; 95% CI: 1.378 -5.175) [27] .
Hypertensive patients with co-morbidities were 50% less likely to be adherent to their medications compared to patients with no co-morbidity (AOR = 0.50: 95% CI: 0.290 -0.893) in Ethiopia [36] . In Bangladesh, hypertensive patients with cardiovascular co-morbidity were significantly associated with MNA (AOR = 0.79; 95% CI: 0.64 -0.97) [29] . A study in north-west Ethiopia [37] also found that patients with no and one co-morbidity were more likely to adhere to their treatment than those with two (AOR = 2.50, 95% CI: 1.01 -6.21) or more than two co-morbidities (AOR = 2.68, 95% CI: 1.07 -6.71). However, having no other chronic disease ( = 0.009) was a significant factor influencing MNA among hypertensive patients in Palestine [38] .
In Ghana and Nigeria, patients who used herbal preparations for the treatment of hypertension were more likely to show MNA ( = 0.014) [26] . In a qualitative study in Pakistan, [39] almost all the hypertensive patients surveyed firmly supported the utilisation of traditional or herbal remedies for the control of their high BP and confirmed that usually only in the case of failure of these therapies would they seek help from modern or biomedical health care providers. A qualitative study in Nigeria found some patients with low medication adherence substituted or complemented prescribed pills with herbal remedies on their own without informing their doctor [40] .
Psychosocial Factors
Seven studies reported significant associations between psychosocial variables (such as family support, depression and use of social drugs) and MNA to hypertensive treatment (Table 2 ).
An absence of household support had a strong negative effect on adherence among hypertensive patients in Ethiopia (AOR = 0.170, 95% CI: 0.030 -0.905) [46] and Nigeria (p < 0.05) [47] . Likewise, studies [41] [49] in Congo reported that patients who received no support from family members regarding reminders about taking their medications were likely to be more non-compliant than the others. A qualitative study in Congo [49] found that there was a perception among some family members that the hypertensive patient had brought the condition upon him-/herself by being a bad person: "They say I developed hypertension because I killed her sister' (through witchcraft)." Though family cohesion is very high in Bangladesh, lack of an accompanying person to go to the physician/hospital was a significant factor in determining non-adherence to antihypertensive treatment (OR = 3.54; 95% CI: 1.04 -11.99) [34] . This lack of Open Journal of Epidemiology Bhandari et al. [33] .
MMAS 4
Nepal; N = 154 support may be due to lack of knowledge of the family members about the disease process. When patients are depressed, they are less likely to follow health care providers' treatment plan for hypertension. In Ghana and Nigeria [26] MNA occurred in patients who had varying degrees of depression (r = −0.208, P < 0.001) (r = Pearson's correlation coefficient).
A World Health Organization report observed that alcohol abuse and tobacco smoking were important modifiers of compliance behaviour. Patients' habit of alcohol consumption, [29] [48] tobacco chewing, [48] and smoking [29] [48]
[50] were strongly associated with poor adherence to anti-hypertensive treatment in studies in India, Iran and Ethiopia. In contrast, a study in Nepal did not found any significant association between tobacco use and alcoholism with MNA among hypertensive study participants [33] .
Perceptions Regarding Hypertension and Its Severity
Four studies reported significant associations between variables related to perceptions of hypertension and MNA to hypertensive medications. These factors included: awareness, knowledge and belief of hypertension and knowledge of the severity of hypertension.
Researchers found that poor understanding and belief in high blood pressure were significant factors associated with MNA in Bangladesh (AOR = 12.90; 95% CI: 1.65 -100.63) [34] and in Ethiopia (P < 0.01) [35] . A qualitative study in Pakistan [39] revealed that once patients achieved control of their high BP, they tended to discontinue their medications. Those patients with an inadequate knowledge of hypertension related complication were also more likely to be non-adherent with the treatment regimen, as found in a study in Bangladesh [34] and Ethiopia [35] (P < 0.01) reported that patients' lack of knowledge about hypertension management was significantly associated with non-adherence to therapy. A significant correlation between beliefs about medication and MNA was found among hypertensive patients in Ghana and Nigeria [26] with patients who were worried about the adverse effects of antihypertensive drugs less likely to be adherent to their medications (r = −0.0347, P = 0.002). Qualitative studies in Pakistan [39] and Malaysia [51] also found patients hesitated to take medications continuously due to their lack of belief in medications. As one hypertensive patient in Pakistan commented: "Medications are hot (warm) in nature. They enter the stomach and increase temperature which interferes with digestion." A study in Palestine found that patients with hypertension were not adhering to their medication due to the fear of dependent on medicines (AOR = 8.00; 95% CI: (2. 44 -26.19) [38] . Similarly avoiding side effects of drugs (AOR = 3.0; 95% CI: 1.4 -6.7) was an important reason for non-adherence to their treatment regimen among hypertensive patients in Nigeria [42] .
Hypertensive patients who did not understand their drug regimen well were poorly adherent to their prescribed medications (AOR = 4.06, 95% CI: 1.01 -16.32) in India [30] and Ethiopia (AOR = 0.12, 95% CI = 0.258 -0.583) [36] . Gelaw et al. [35] found that insufficient information about the consequence of non-adherence to hypertension treatment contributed to the non-adherence of the hypertensive patients in Ethiopia. In Nigeria, a qualitative study also found ignorance about regular use of medication was an important contributor to medication non-adherence [40] .
Perceived Barriers to Adherence
Sixteen studies found significant associations between aspects related to perceived barriers and MNA. These perceived barriers were: the cost of medications, the number of pills that needed to be taken on a daily basis, forgetfulness, side effects of medications, duration of therapy, satisfaction with the treatment and health services provided, and distance from health care centre (Table 4 ). Ambaw et al. [37] .
MMAS 4 Ethiopia; N = 384 Open Journal of Epidemiology
In non-adherent patients surveyed in Nepal, a significantly greater proportion of patients considered the price of medications to be too high (AOR = 5.14; 95% CI: 1.1 -23.9) [33] and for which they missed taking their medications (AOR = 0.143; 95% CI: 0.02 -0.78). The cost of medicine was also a significant factor associated with MNA among patients in Congo (OR = 1.84; 95% CI: 0.93 -3.64) [41] . Similarly, the inability to buy medications (P < 0.001) was positively and significantly related to MNA in Sudan [52] . Even being able to afford only some of the prescribed antihypertensive drugs (AOR = 3.70, 95% CI: 1.81 -7.59) was also significantly related with MNA in India [30] .
In Nepal, non-adherence was significantly associated with therapy requiring more than one pill per day (AOR = 5.33; 95% CI: 1.19 -23.7) compared to patients prescribed only one pill per day [33] . MNA was also greater among patients with higher pill burden in India, [53] Nigeria, [47] and Malaysia [54] (P < 0.05). On the other hand, a couple of studies [44] [55] found that when patients had to take multiple medications, perhaps, they were less likely to fail to remember to take them, compared to having only one pill. A study in Pakistan [44] found non-adherence was higher among those patients who were on monotherapy and di-therapy compared to patients using 3 or >3 drugs (P = 0.02).
Patients also often forget to take even once daily medications. Studies in Nigeria (OR = 14.8; 95% CI: 3.9 -54.8) [42] and Palestine (AOR = 5.12; 95% CI: 3.12 -8.41) [38] found significant correlation between forgetfulness and nonadherence among hypertensive patients.
Hypertensive patients who experienced side effects of their medications were less adherent to their medication than those who did not experience side effects in Palestine (AOR = 4.58; 95% CI: 1.87 -11.25) and Serbia (OR = 7.95; 95% CI: 1.48 -42.6) [28] [38] . Qualitative studies in Malaysia [51] and Nigeria [40] also found perceived side effects were inhibitors of antihypertensive medication adherence. However, Praveen et al. [30] in India did not find a correlation between adverse drug events and non-adherence.
Patients who had had a diagnosis of hypertension of five or more years were less likely to adhere to treatment than those who had been diagnosed for less than five years in Nepal [33] (OR = 2.98; 95% CI: 1.73 -5.14) and Ethiopia (AOR = 0.11, 95% CI: 0.013 -0.955) [45] . Lower levels of adherence in elderly patients with longer duration of antihypertensive therapy were also found in Serbia [28] . On the other hand, patients with shorter duration of hypertension were less likely to be adherent to treatment in Pakistan (<5 years) (AOR = 0.11, 95% CI: 0.013 -0.955) [44] and China (<3 years) (AOR = 3.31; 95% CI: 1.91 -5.72; P < 0.001) [56] .
Distance from health care facilities was a significant barrier for adherence to treatment. Longer distance from medical centres contributed to MNA of hypertensive patients in Ethiopia [35] . In the same way, those living in rural areas had poorer adherence to hypertensive medications in Palestine than those living in urban areas (AOR = 1.79; 95% CI: 1.10 -2.92) [38] . As the remoteness from the hospital decreased, adherence to hypertension treatment improved (AOR = 2.02; Open Journal of Epidemiology 95% CI: 1.19 -3.43) in Ethiopia [37] .
Treatment and/or Disease Related Factors
Eleven studies found a number of treatment or disease related factors associated with MNA. These included absence of disease symptoms, complication, irregular follow-up, family history of hypertension and poor BP control ( Table 5 ).
The absence of symptoms significantly contributed to poor compliance to hypertensive therapy in Nigeria (AOR = 3.3; 95% CI: (1.3 -8.0) [42] and India (OR = 0.414; 95% CI: 0.192 -0.892) [27] . Qualitative studies in Congo [49] and India [58] also found hypertensive medications were more likely to be taken when the patient experienced symptoms of hypertension.
The presence of hypertension-related complications such as heart diseases (AOR = 21.73, 95% CI: 1.568 -418.42 P = 0.000) was found to be associated with decreased medication adherence among patients in Ethiopia [46] . In contrast, a study in Pakistan found that cases suffering from hypertension-related complications were more likely to be adherent to medications [57] .
In Nepal, those with no family history of hypertension were less adherent to their medications compared to those with a family history of high BP (OR = [28] . Similarly, the average systolic and diastolic blood pressure for non-adherents was significantly higher (P = 0.05) than that in adherents in Malaysia [54] . In contrast, a study in Northern Ethiopia [46] found that patients at the pre-hypertension level (BP values below 140/90 mmHg) (AOR = 0.026; 95% CI: 0.003 -0.242) were less adherent to their medications.
Health Care Services
Four studies found dissatisfaction with the health services and treatment provided' influenced MNA significantly among hypertensive patients (Table 6) . A study conducted in Brazil confirmed the high correlation between MNA and dissatisfaction with health services [60] . Hypertensive individuals who were dissatisfied with the care received in primary public health services (such as reception service, scheduling appointment and care received from the health team)
were more likely to not adhere to the proposed medication treatment. Inconve- 
Summary of the Result
The results of the review provide insight into factors influencing MNA of hyper- 
Discussion
Though non-adherence to antihypertensive treatment is a significant problem in CHD management few studies on medication adherence have been conducted in developing countries [61] . Moreover, the majority of these studies were conducted in hospital and clinical settings. Studies carried out in low-income community settings are extremely limited.
Our review found that although there was substantial heterogeneity in methods and populations across studies, approximately half of the participated hypertensive population both male and female 18 years and older did not adhere properly to the treatment for hypertension as prescribed by their doctors. De-Open Journal of Epidemiology spite the higher prevalence of hypertension and its poor control among women in developing countries, we did not find any studies that focused specifically on this vulnerable population.Women in developing countries living with chronic non-communicable diseases such as hypertension experience particular challenges in accessing cost-effective prevention, early detection, diagnosis, treatment and care. The lack of knowledge and information regarding health, poor access to healthcare, family responsibilities, and poor economic, legal and political status further worsen their situation [62] .
From 25 studies, we identified significant factors associated with MNA. A limitation of the selected studies was the fact that factors associated with MNA
were not examined for gender differences. However, a study in Brazil reported reasons for non-adherence to medication and non-medication regimen in patients' opinion according to gender [63] . Considering the magnitude of inadequately treated or controlled hypertension among women in developing countries, studies that explore factors affecting MNA in this vulnerable population areurgently needed.
Implications for Hypertension Management and Research
The present review reveals that gender may not be a good predictor of non-adherence because of inconsistent conclusions. However, it is conceivable that women with low socioeconomic status and lower level of education are more vulnerable. Their lack of adherence might be due to their inability to buy medicines, and lack of access to free health facilities as governments in developing countries spends comparatively less of their budgets on health than developed countries. The importance of cost-related factors should be considered against the background of the relatively high out-of-pocket payments for most treatments in developing countries especially in South Asia and Africa.
The review also found that fear of side effects make some hypertensive patients stop their medications or reduce their daily doses without consulting their health care providers. Therefore, information tailored to patient's literacy level about the side effects of prescribed medications and how to manage these should be provided to all patients. From the review, it appears that educational level may not be a good predictor of MNA. However, sceptical attitudes towards antihypertensive treatment even among educated participants necessitate the health education on hypertension and its treatment to all hypertensive patients irrespective of the patients' educational status. Understanding potential complications of hypertension could be a motivating factor for adherence to treatment. For this to happen, patients need to be aware of the seriousness of their condition and all risks involved without being worried unnecessarily [64] . To better deal with these problems, educational interventions are required that recognise patients' apprehension and perceptions. In particular, patients should be provided an explanation of the benefits and adverse effects of treatment. The safety of long-term use of drugs needs to be discussed, including the information that treatment Open Journal of Epidemiology does not cause physical dependence irrespective of the length of treatment. The review indicated that adherence to antihypertensive medication treatment would be improved if patients experience positive encounters with their doctors or health care providers regarding adequate and accurate advice on achieving control of their high blood pressure [65] . Among the selected studies, there was a general lack of assessment of individual risk perceptions of hypertension complications such as CHD. This is an unfortunate omission given the importance of such risk perceptions in medication adherence. Earlier studies in developed countries have shown that patients who accurately perceive their risk of cardiovascular disease are more likely to be adherent to medications and guidelines compared to those who do not perceive themselves to be at risk [66] [67] [68] [69]. Women's perceptions of their risk for heart disease can significantly influence their decision-making process concerning healthcare choice [70] .
The studies in the review did not examine in depth cultural and psychological issues, in particular those relating to self-efficacy (i.e. the belief that one can perform a particular behavior under differing conditions which can greatly impact on medication adherence. Cultural restrictions make it difficult for women to seek medical care from male health care providers, [71] but there is, at the same time, a shortage of female health professionals [71] . These issues are compounded by health systems that often fail to respond to the particular needs of women with NCDs such as hypertension [72] . Weak health systems have been identified as a major obstacle in effectively responding to the rising burden of chronic conditions such as hypertension in developing countries. Studies are required that recognise and analyse the intricate associations between health systems and their effects on hypertension management in developing countries [73] . In spite of the need for research on health systems, little attention has also been given to the role of local health systems in the delivery of care for the control of hypertension. Moreover, belief-laden factors including confidence in the physician's knowledge or ability, belief of control over one's health and illness perception were all found to be significantly related to medication adherence in developed countries [74] . Studies in developing countries especially at community settings on these factors influencing adherence would be helpful to address the knowledge gap and contribute to global strategies for addressing non-compliance among hypertensive patients.
Strengths and Weaknesses of the Review
We have included studies from 20 developing countries (27.40% of all developing countries). Having the study population from less than one third of the developing countries incorporated in the analysis, the conclusions of this review might not be extrapolated to the whole population of the developing countries.
Most of the studies in our review that met inclusion criteria were quantitative in type. Only half of the quantitative studies (20) chose study participants using simple or systematic random sampling techniques. Eight studies used purposive sampling method, thus their results may not be necessarily generalisable to the Open Journal of Epidemiology wider population. The remaining studies selected all eligible hypertensive patients from clinics/hospitals or communities as their study participants.
The review followed the PRISMA reporting guidelines for identifying, reporting, and synthesising research. The results of the review are robust. Most of studies selected for the review were judged to be of moderate to strong quality in terms of research rigour, reliability and validity. A large number of MNA related factors were consistently identified across different countries. However, this review was subject to a few limitations. This study included only English peer-reviewed journal articles. The majority of the studies relied solely on self-reported adherence, which may be subject to self-presentation and recall bias. Moreover, heterogeneity in important aspects of methodology of the selected studieslimits the results that can be drawn from the synthesis of the data.MNA may also be influenced by the time in which the study was performed.Among the selected quantitative studies, only two prospective cross-sectional studies were found. Longitudinal assessment is desirable to differentiate between chronic and occasional nonadherence and related barriers that may contribute to non-adherence.
Conclusion
This systematic review examined the prevalence of MNA among hypertensive population as well as investigated factors affecting MNA. Approximately half of hypertensive men and women were found to be non-adherent to their medications. Among the selected studies, very few studies were conducted in low-income community settings. MNA was influenced by a range of factors including socio-economic status, knowledge of hypertension and its management, medication side effects, costs of medication, and dissatisfaction with the treatment and health services provided. There was a general lack of consideration of cultural barriers, role of health system in health care delivery, self-efficacy, and perceived individual risk of hypertension complications. Policymakers and health service providers should take these factors into account to tailor culturally appropriate intervention strategies to enhance adherence among hypertensive patients. There is also a lack of gender-specific research which is necessary given the social and economic vulnerabilities faced by women in developing countries that may affect adherence to antihypertensive medications. Adherence showed association with concern about medications (r = −0.0347, p = 0.002) and knowledge of hypertension (r = 0.14, p = 0.006). MNA was related with: depression (r = −0.208, p < 0.001), formal education (p = 0.001), younger age (p = 0.000), use of herbal preparation (p = 0.014), insured participants (p = 0.032) and poor BP control (p = 0.006). The participants exhibited poor adherence with lifestyle factors like unrestricted meal habits (OR = 4.8), alcohol consumption (OR = 3.1), smoking (OR = 12.9), and salt intake > 5 gm (OR = 3.6). Adherence was significantly higher among respondents taking only one medication and once daily compared with individuals taking four types of medication and as frequent as three or more times a day. 
